celgene

Celgene to pay Evotec $65 million in cancer drug pact




celgene

Celgene partners with Skyhawk Therapeutics to drug RNA with small molecules

Skyhawk will receive $60 million up front to develop drug candidates that target RNA in neurological diseases




celgene

Celgene to pay Evotec $65 million in cancer drug pact




celgene

Celgene partners with Skyhawk Therapeutics to drug RNA with small molecules

Skyhawk will receive $60 million up front to develop drug candidates that target RNA in neurological diseases